Novel Coronavirus (SARS-CoV-2/COVID-19)
The Centers for Medicare & Medicaid Services issued new surveyor guidance for COVID-19 laboratory test result reporting for Clinical Laboratory Improvement Amendments-certified laboratories.
Senate Republican leaders released a roughly $500 billion COVID-19 relief package that would provide additional assistance for priorities, including small businesses, enhanced unemployment insurance, child care, COVID-19 testing and schools.
The AHA urged the National Academies of Sciences, Engineering and Medicine to adopt a unified set of guidelines to account for the variables associated with all issues of the eventual allocation of COVID-19 vaccine allocation.
AHA has compiled several case examples demonstrating the struggles and successes of rural hospitals battling COVID-19 in their communities.
AHA urges the Centers for Medicare & Medicaid Services (CMS) to withdraw the condition of participation that hospitals report daily COVID-19 data.
For the last several months, disturbing and unproven theories have gained traction – mostly on social media – about the death count for COVID-19.
Hospitals and health systems are eligible to receive higher payments for complex COVID-19-related treatment under the CARES Act – that much is true.…
In this podcast, Rebecca Chickey, senior director of field engagement, behavioral health services of the AHA is speaking with Martha Whitecotton, senior vice president of Behavioral Health Services at Atrium Health in Charlotte North Carolina, about using telehealth visits to provide behavioral…
The AHA yesterday urged President Trump and the Department of Health and Human Services to continue to act on behalf of rural hospitals and health systems to address rural health care concerns. In a letter to the president, AHA recommended steps that support rural hospitals that are facing dire…
The National Academies of Sciences, Engineering, and Medicine today released for public comment a discussion draft of a preliminary framework to assist policymakers in planning for equitable allocation of a vaccine against COVID-19.
The Food and Drug Administration further expanded the authorized use of remdesivir for treating COVID-19 patients, the agency announced. Now, remdesivir can be used for all admitted COVID-19 patients, confirmed or suspected, whether on oxygen, off oxygen or intubated.